Health & biology · 2023
Casgevy, first CRISPR therapy
The first approved CRISPR medicine freed sickle cell patients from painful crises.
Vertex and CRISPR Therapeutics' Casgevy edits patients' blood stem cells to restore fetal haemoglobin. The UK approved it in November 2023 and the US in December 2023.
What it built on 1
What it led to 1
Related measurements
The dashed line marks when it first worked.
Cost to sequence a human genome Latest: 525 $ (2022) Source: Our World in Data